Global Addiction Treatment Market: Overview This report on the addiction treatment market analyzes the current and future scenario of the global market. Awareness initiatives by different drug manufacturers, government bodies and growing abuse of prescription drugs are the major drivers of the global addiction treatment market during the forecast period.
The global addiction treatment market report comprises a detailed elaborate executive summary, which includes market snapshot that provides information about various segments.It also provides information and data analysis of the country’s market with respect to the segments based on treatment type, drug type, treatment centers, and distribution channels.
An elaborated qualitative analysis of drivers and trends has been provided in the market overview section. This section also provides market attractiveness analysis in terms of country, thus presenting a thorough analysis of the overall competitive scenario in the global addiction treatment market.
Global Addiction Treatment Market: Segmentation Based on treatment centers, the global addiction treatment market is classified into alcohol addiction treatment, tobacco/nicotine addiction treatment, opioid addiction treatment and other substance addiction treatment.The market segments have been analyzed based on awareness of addiction treatment, actual percentage accessing different insurance policies for treatment, and medical scenarios.
The market size and forecast for each of these segments have been provided for the period from 2015 to 2025, along with their respective CAGR for the forecast period from 2017 to 2025, considering 2016 as the base year.
Based on drug type, the market has been segmented into bupropion, varenicline, acamprosate, disulfiram, naltrexone, methadone, buprenorphine, nicotine replacement products and others.In term of treatment centers, the market has been segmented into outpatient treatment centers, residential treatment centers, and inpatient treatment centers.
Based on distribution channels, the addiction treatment market segmented into hospital pharmacy, medical stores and others. The distribution channels segmentation has been analyzed on the basis of purchase of drugs which is prescribed for addiction treatment.
The market segments have been extensively analyzed based on drugs and products used in the treatment of addiction, centers that have been widely used for treatment and medical reimbursements.The market size and forecast in terms of value (US$ Mn) for each segment have been provided for the period from 2015 to 2025.
The report also provides the compound annual growth rate (CAGR %) for each market segment for the forecast period from 2017 to 2025, considering 2016 as the base year.
Global Addiction Treatment Market: Regional Analysis Geographically, the global addiction treatment market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The market size and forecast for each of these regions have been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2016 as the base year.
The report also profiles major players in the global addiction treatment market based on various attributes such as company overview, financial overview, product portfolio, business strategies, SWOT analysis, and recent developments.
The key players operating in the global addiction treatment market are Cipla Ltd., Allergan plc, Alkermes plc, Pfizer Inc., Orexo AB, GlaxoSmithKiline plc, Purdue Pharma L.P, Mallinckrodt, and Reckitt Benckiser (Indivior PLC) among others.
The global addiction treatment market is segmented as follows:
By Treatment Type Alcohol Addiction Treatment Tobacco/Nicotine Addiction Treatment Opioid Addiction Treatment Other Substance Addiction Treatment
By Drug Type Bupropion Varenicline Acamprosate Disulfiram Naltrexone Methadone Buprenorphine Nicotine replacement products Others surgical
By Distribution Channels Hospital pharmacy Medical stores Others
By Region North America U.S. Canada Europe Germany France U.K. Spain Italy Rest of Europe Asia Pacific (APAC) China Japan India Australia & New Zealand Rest of APAC Latin America (LATAM) Brazil Mexico Rest of LATAM Middle East & Africa (MEA) South Africa GCC Countries Israel Rest of MEA
Our reports have been used by over 10K customers, including:
This 42-page report provides detailed analyses of current and emerging hematology and flow cytometry technologies, and their potential market applications, including IT and robotics, lasers, monoclonal antibodies, molecular diagnostics, microdrop and others.The report also presents strategic assessments of current and emerging suppliers...
The infertility treatment market is expected to grow at a CAGR of over 6% during the forecast period 2018–2024. The growing prevalence of infertility among men and women is increasing the demand for sterility treatment globally. Factors such as delayed parenthood, obesity, sexually transmitted infections (STIs), and aging is increasing...
Human Papillomavirus Infections Global Clinical Trials Review, H1, 2020 Summary clinical trial report, “Human Papillomavirus Infections Global Clinical Trials Review, H1, 2020 provides an overview of Human Papillomavirus Infections Clinical trials scenario.This report provides top line data relating...
House Dust Mite Allergy - Pipeline Review, H1 2020 Summary The latest Pharmaceutical and Healthcare disease pipeline guide House Dust Mite Allergy - Pipeline Review, H1 2020, provides an overview of the House Dust Mite Allergy (Immunology) pipeline landscape. House dust mite allergy is an...
Transforming Growth Factor Beta 1 - Pipeline Review, H1 2020 Summary According to the recently published report ’Transforming Growth Factor Beta 1 (TGFB1) - Pipeline Review, H1 2020’; Transforming Growth Factor Beta 1 (TGFB1) pipeline Target constitutes close to 27 molecules. Out of which approximately...
High Affinity Nerve Growth Factor Receptor - Pipeline Review, H1 2020 Summary High Affinity Nerve Growth Factor Receptor (Neurotrophic Tyrosine Kinase Receptor Type 1 or TRK1 Transforming Tyrosine Kinase Protein or Tropomyosin Related Kinase A or Tyrosine Kinase Receptor or gp140trk or p140 TrkA...
RAC Beta Serine/Threonine Protein Kinase - Pipeline Review, H1 2020 Summary RAC Beta Serine/Threonine Protein Kinase (Protein Kinase Akt 2 or Protein Kinase B Beta or RAC PK Beta or AKT2 or EC 184.108.40.206) pipeline Target constitutes close to 9 molecules. The latest report RAC Beta SerineThreonine Protein...
Tyrosine Protein Kinase SYK - Pipeline Review, H1 2020 Summary Tyrosine Protein Kinase SYK (Spleen Tyrosine Kinase or p72 Syk or SYK or EC 220.127.116.11) - Spleen tyrosine kinase, also known as Syk, is an enzyme encoded by the SYK gene. It regulates several biological processes including innate and adaptive...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.